EX1 Insider Trading

Insider Ownership Percentage: 38.21%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Exopharm Insider Trading History Chart

This chart shows the insider buying and selling history at Exopharm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exopharm Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for EX1 up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Exopharm Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2023Clarke BarlowInsiderIssued10,000,000A$0.01A$110,000.00
4/28/2023Jason WatsonInsiderIssued380,000A$0.01A$3,800.00
9/1/2021Ian DixonInsiderExercise83,333A$0.54A$44,583.16
See Full Table

SEC Filings (Institutional Ownership Changes) for Exopharm (ASX:EX1)

Exopharm Limited develops transformative medicines based upon exosomes or extracellular vesicles (EVs) in Australia. The company's technology includes LOAD technology platform that enables loading of active pharmaceutical ingredient (API) into exosomes; Ligand-based Exosome Affinity Purification (LEAP) technology that solves the critical bottleneck of exosome isolation and purification; MASTER CELL BANK to manufacture clinical-grade engineered exosomes; EVPS technology platform that allows specific molecules to be attached to the surface of exosomes to target them to selected tissues, organs, or cell types; EXORIA, a novel and proprietary dye that tags invisible exosomes to enhance tracking in experimental studies and laboratory analysis; and FORMULATION H to enable the stable storage and transport of exosome medicines. Exopharm Limited has research collaboration agreements with Astellas Institute for Regenerative Medicine. The company was incorporated in 2013 and is based in Camberwell, Australia.
Read More on Exopharm

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Exopharm?

Exopharm's top insider shareholders include:
  1. Clarke Barlow (Insider)
  2. Jason Watson (Insider)
Learn More about top insider investors at Exopharm.